BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 35866781)

  • 21. Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
    Sun S; Guo W; Wang Z; Wang X; Zhang G; Zhang H; Li R; Gao Y; Qiu B; Tan F; Gao Y; Xue Q; Gao S; He J
    Cancer Med; 2020 Aug; 9(16):5960-5975. PubMed ID: 32592319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a Pyroptosis-Related Gene Signature for Prediction of Overall Survival in Lung Adenocarcinoma.
    Dong Z; Bian L; Wang M; Wang L; Wang Y
    J Oncol; 2021; 2021():6365459. PubMed ID: 34630565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes.
    Xiong Z; Zhang L; Fan W
    J Immunol Res; 2022; 2022():6084589. PubMed ID: 35935579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma.
    Song J; Sun Y; Cao H; Liu Z; Xi L; Dong C; Yang R; Shi Y
    Bioengineered; 2021 Dec; 12(1):5932-5949. PubMed ID: 34488540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
    Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
    Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation.
    Gong M; Liu X; Zhao X; Wang H
    BMC Cancer; 2022 Sep; 22(1):1005. PubMed ID: 36138348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
    Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
    Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
    He J; Zhang W; Li F; Yu Y
    Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma.
    Niu W; Jiang L
    Math Biosci Eng; 2021 Jul; 18(5):6136-6154. PubMed ID: 34517527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
    Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
    BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of
    Bian T; Zhang W; Wang F; Chu X; Pan X; Ruan J; Yu S; Liu L; Sun H; Qiu H; Li Y; Tang J; Zhao X; Zhang H
    Comb Chem High Throughput Screen; 2023; 26(14):2452-2468. PubMed ID: 37038295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma.
    Liu L; He H; Peng Y; Yang Z; Gao S
    PeerJ; 2021; 9():e11911. PubMed ID: 34631307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma.
    Ren J; Wang A; Liu J; Yuan Q
    Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.